Stay updated on Obeldesivir Study in High-risk COVID-19: Clinical Trial

Sign up to get notified when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Obeldesivir Study in High-risk COVID-19: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Page revision note updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T23:46:47.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A new citation for SARS-CoV-2 resistance analyses from the Phase 3 BIRCH study was added, and the earlier version of that citation was removed.
    Difference
    0.0%
    Check dated 2026-02-25T18:59:46.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Added Clin Infect Dis publication on BIRCH (2026) and removed older funding notice.
    Difference
    0.3%
    Check dated 2026-02-11T11:59:10.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and NIH operating status with links to cc.nih.gov and opm.gov. Updated the site to revision v3.4.1, replacing v3.4.0.
    Difference
    0.3%
    Check dated 2026-02-04T06:34:23.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now includes a glossary option, adds a new cited publication (SARS-CoV-2 Resistance Analyses...), and updates several metadata labels including QC-related entries and the revision tag.
    Difference
    0.2%
    Check dated 2026-01-28T04:18:19.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 removed. This is a minor metadata update to the page.
    Difference
    0.0%
    Check dated 2026-01-14T01:46:10.000Z thumbnail image

Stay in the know with updates to Obeldesivir Study in High-risk COVID-19: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.